{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:04:18Z","timestamp":1792555458593,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.nucmedbio.2004.04.007","type":"journal-article","created":{"date-parts":[[2004,10,4]],"date-time":"2004-10-04T19:02:24Z","timestamp":1096916544000},"page":"909-919","source":"Crossref","is-referenced-by-count":22,"title":["Evaluation of an internalizing monoclonal antibody labeled using N-succinimidyl 3-[131i]iodo-4-phosphonomethylbenzoate ([131i]SIPMB), a negatively charged substituent bearing acylation agent"],"prefix":"10.1016","volume":"31","author":[{"given":"Sriram","family":"Shankar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Vaidyanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna J.","family":"Affleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darell D.","family":"Bigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Zalutsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB1","first-page":"588","article-title":"Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues","volume":"55","author":"Damjanov","year":"1986","journal-title":"Lab Invest"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB2","first-page":"71","article-title":"Growth factor receptors as molecular targets for cancer diagnosis and therapy","volume":"41","author":"Zalutsky","year":"1997","journal-title":"Quart J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB3","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1073\/pnas.89.10.4309","article-title":"Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and\/or C-terminal tails","volume":"89","author":"Ekstrand","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB4","first-page":"2231","article-title":"Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts","volume":"48","author":"Humphrey","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB5","first-page":"5536","article-title":"Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors","volume":"55","author":"Moscatello","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB6","first-page":"3140","article-title":"Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas","volume":"55","author":"Wikstrand","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1021\/bc025636p","article-title":"N-Succinimidyl 3-[131I]iodo-4-phosphonomethylbenzoate ([131I]SIPMB), a negatively charged substituent-bearing acylation agent for the radioiodination of peptides and mAbs","volume":"14","author":"Shankar","year":"2003","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/13550289809114515","article-title":"The class III variant of the epidermal growth factor receptor (EGFRvIII)","volume":"4","author":"Wikstrand","year":"1998","journal-title":"J. NeuroVirol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB9","first-page":"2907","article-title":"Intracellular catabolism of radiolabeled anti-\u03bc antibodies by malignant B-cells","volume":"52","author":"Geissler","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB10","first-page":"2123","article-title":"Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells","volume":"56","author":"Press","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB11","first-page":"381","article-title":"Biodistribution of p-iodobenzoyl (PIP) labeled antibodies in murine lymphoma model","volume":"17","author":"Badger","year":"1990","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB12","first-page":"727","article-title":"Synthesis of 125I labeled N-succinimidyl p-iodobenzoate for use in radiolabeling antibodies","volume":"16","author":"Khawli","year":"1989","journal-title":"Nuc Med Biol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB13","first-page":"283","article-title":"Improvements in radioiodination of monoclonal antibodies for diagnosis and treatment of cancer","volume":"4","author":"Quadri","year":"1991","journal-title":"Antibody Immunoconjugates Radiopharm"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB14","first-page":"216","article-title":"Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer","volume":"30","author":"Wilbur","year":"1989","journal-title":"J Nuc Med"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0883-2889(87)90069-4","article-title":"A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine","volume":"38","author":"Zalutsky","year":"1987","journal-title":"Int J Radiat Appl Instrum [Part A]"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB16","first-page":"4970","article-title":"Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate","volume":"56","author":"Reist","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB17","first-page":"4453","article-title":"Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody","volume":"60","author":"Foulon","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0969-8051(01)00239-6","article-title":"Positively charged templates for labeling internalizing antibodies","volume":"28","author":"Foulon","year":"2001","journal-title":"Nuc Med Biol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB19","first-page":"1510","article-title":"Improved targeting of an anti-EGFRvIII monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate","volume":"57","author":"Reist","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB20","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/bc0001490","article-title":"A polar substituent-containing acylation agent for the radioiodination of internalizing monoclonal antibodies","volume":"12","author":"Vaidyanathan","year":"2001","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0969-8051(01)00277-3","article-title":"Improved xenograft targeting of tumor specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate","volume":"29","author":"Vaidyanathan","year":"2002","journal-title":"Nuc Med Biol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB22","first-page":"422","article-title":"The pharmacokinetic characteristics of glycolated humanized anti-tac Fabs are determined by their isoelectric points","volume":"59","author":"Kobayashi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0969-8051(98)00017-1","article-title":"The in vivo behavior of Copper-64-labeled azamacrocyclic complexes","volume":"25","author":"Jones-Wilson","year":"1998","journal-title":"Nuc Med Biol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/jm0103817","article-title":"Radiolabeling and in vivo behavior of Copper-64-labeled cross-bridged cyclam ligands","volume":"45","author":"Sun","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB25","series-title":"The Kidney","first-page":"3005","article-title":"Filtration, transport, and metabolism of proteins","author":"Maack","year":"1992"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB26","first-page":"4375","article-title":"Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies","volume":"55","author":"Reist","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0022-1759(84)90435-6","article-title":"Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess","volume":"72","author":"Lindmo","year":"1984","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB28","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1073\/pnas.91.16.7727","article-title":"A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity","volume":"91","author":"Nishikawa","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB29","first-page":"4130","article-title":"Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor EGFRvIII","volume":"57","author":"Wikstrand","year":"1997","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB30","first-page":"1052","article-title":"Enhancement of radiation dose to the nucleus by vesicular internalization of iodine-125-labeled A33 monoclonal antibody","volume":"37","author":"Daghighian","year":"1997","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB31","first-page":"557","article-title":"Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies","volume":"15","author":"Ali","year":"1988","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB32","doi-asserted-by":"crossref","first-page":"14122","DOI":"10.1016\/S0021-9258(18)68193-1","article-title":"Inulin-125I-tyramine, an improved residualizing label for studies on sites of catabolism of circulating proteins","volume":"263","author":"Maxwell","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/bj2120791","article-title":"A radioiodinated, intracellularly trapped ligand for determining the sites of plasma protein degradation in vivo","volume":"212","author":"Pittman","year":"1983","journal-title":"Biochem J"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1096\/fasebj.7.5.8462781","article-title":"The design and application of residualizing labels for studies of protein catabolism","volume":"7","author":"Thorpe","year":"1993","journal-title":"FASEB J"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/bc980075g","article-title":"Labeling of monoclonal antibodies with diethylene-triaminepentaacetic acid-appended radioiodinated peptides containing D-amino acids","volume":"10","author":"Govindan","year":"1999","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB36","first-page":"111","article-title":"Improved iodine radiolabels for monoclonal antibody therapy","volume":"63","author":"Stein","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB37","first-page":"967","article-title":"Radioimmunotherapy of a lung cancer xenograft with monoclonal antibody RS7","volume":"42","author":"Stein","year":"2001","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1040-8428(01)00106-8","article-title":"Successful therapy of a human lung cancer xenograft using MAb RS7 labeled with residualizing radioiodine","volume":"39","author":"Stein","year":"2001","journal-title":"Crit Rev Oncol Hemat"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1440-1746.1999.01886.x","article-title":"Molecular aspects of organic compound transport across the plasma membrane of hepatocytes","volume":"14","author":"Kamisako","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0168-8278(99)80054-3","article-title":"Regulation of organic anion and drug transporters of the sinusoidal membrane","volume":"31","author":"Kullak-Ublick","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2004.04.007_BIB41","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U","article-title":"Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv","volume":"88","author":"Kuan","year":"2000","journal-title":"Int J Cancer"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805104000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805104000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T05:10:55Z","timestamp":1624684255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805104000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0969805104000800"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2004.04.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}